A phase II study of erlotinib in gemcitabine refractory advanced pancreatic cancer.
Renouf DJ, Tang PA, Hedley D, Chen E, Kamel-Reid S, Tsao MS, Tran-Thanh D, Gill S, Dhani N, Au HJ, Wang L, Moore MJ.
Renouf DJ, et al. Among authors: hedley d.
Eur J Cancer. 2014 Jul;50(11):1909-15. doi: 10.1016/j.ejca.2014.04.008. Epub 2014 May 21.
Eur J Cancer. 2014.
PMID: 24857345
Clinical Trial.